RecruitingNCT05962229
Natural, synthetic or mixed nicotine in experienced vape users
About this title
Read the official source — NCT05962229Medication studyAges 21–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 6, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 18
- Sponsor
- University of California, San Francisco
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT05962229
- Official title
Show the full official title
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Francisco, a university.
Does this study involve medication?
Yes. The study involves medication, including (S)-Nicotine, (R)- nicotine and Racemic nicotine.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
